Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2 COVID-19 Vaccine Candidate in The New England Journal of Medicine

NEXT STORY
Clene Nanomedicine Presents Blinded Interim Results from RESCUE-ALS Phase 2 Study at the 31st International Symposium on ALS/MND
PREV STORY
Global Pharmaceutical Drug Delivery Market Report 2020-2026: Focus on Oral, Pulmonary, Injectable, Ocular, Nasal, Topical, Implantable, Transmucosal Drug Delivery
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

New Study From Trusted Health Finds Significant Decline in Nurses’ Mental Health and Well-being in the Wake of COVID-19, Yet Commitment to the Profession Remains High

author_avatar
NASDAQ Market News

Dova Pharmaceuticals Reports Second Quarter 2018 Operating and Financial Results

DOPTELET approved by FDA on May 21, 2018 DOPTELET launched on June 4, 2018 ...

author_avatar
NASDAQ Market News

Precision Medicine Market growing at 10.5% CAGR to hit $96 bn by 2024

Ocean View, Delaware, Oct. 26, 2017 (GLOBE NEWSWIRE) -- Precision Medicine Market is expected ...

author_avatar
NASDAQ Market News